United Gene High-Tech Group Limited announced the board will inform based on a preliminary review of the unaudited consolidated management accounts of the Group for the six months ended December 31, 2013, the group is expected to record a substantial increase in the consolidated net loss for the six months ended December 31, 2013 as compared with the corresponding period in 2012, due to a loss on the acquisition of the convertible bonds issued by Extrawell Pharmaceutical Holdings Limited.